Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data
-
- Shun Kohsaka
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan;
-
- Jun Katada
- Pfizer Japan Inc., Tokyo, Japan;
-
- Kumiko Saito
- Bristol-Myers Squibb K.K., Tokyo, Japan;
-
- Yasuo Terayama
- Department of Gerontology, School of Medicine, Iwate Medical University, Iwate, Japan
収録刊行物
-
- Current Medical Research and Opinion
-
Current Medical Research and Opinion 34 (9), 1627-1634, 2018-05-30
Informa UK Limited